Page 28 - Read Online

Potdar CTCs in cancer diagnosis and treatment

15. Kuhlmann JD, Wimberger P, Bankfalvi A, Keller T, Schöler S, Aktas Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel
B, Buderath P, Hauch S, Otterbach F, Kimmig R, Kasimir-Bauer S. K, Janni W; SUCCESS Study Group. Circulating tumor cells predict
ERCC1-positive circulating tumor cells in the blood of ovarian cancer survival in early average-to-high risk breast cancer patients. J Natl
patients as a predictive biomarker for platinum resistance. Clin Chem Cancer Inst 2014;106:dju066.
2014;60:1282-9. 18. Peeters DJ, van Dam PJ, Van den Eynden GG, Rutten A, Wuyts
16. Alix-Panabières C, Pantel K. Clinical applications of circulating H, Pouillon L, Peeters M, Pauwels P, Van Laere SJ, van Dam PA,
tumor cells and circulating tumor DNA as liquid biopsy. Cancer Vermeulen PB, Dirix LY. Detection and prognostic significance
Discov 2016;6:479-91. of circulating tumour cells in patients with metastatic breast
17. Rack B, Schindlbeck C, Jückstock J, Andergassen U, Hepp P, cancer according to immunohistochemical subtypes. Br J Cancer
Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, 2014;110:375-83.

Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ January 12, 2017 5